2025-12-06 - Analysis Report
Here's a breakdown of the provided data for Schrodinger Inc. (SDGR), followed by a comprehensive analysis.

**0) Basic Numbers and Analysis**

*   **SDGR Cumulative Return:** -55.76%
*   **VOO (S&P 500) Cumulative Return:** 69.44%

This means SDGR significantly underperformed the S&P 500 over the period.

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** Schrodinger Inc is a company that develops software for drug discovery and materials science.
*   **Divergence:** The current divergence from VOO is -127.1, which represents the lowest point in the divergence range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2020-2022  | -70.0% | 78.2%  | -76.0%  | 0.0    | 1.4    |
| 2021-2023  | -57.0% | 81.0%  | -59.0%  | -0.0   | 2.6    |
| 2022-2024  | 6.0%   | 81.0%  | -14.0%  | -0.0   | 1.4    |
| 2023-2025  | -4.0%  | 82.6%  | -70.0%  | -0.0   | 1.3    |

**Analysis:**

*   **Underperformance:** SDGR has consistently underperformed relative to its risk-adjusted return (negative Alpha) and has negative CAGR values for almost all the periods.
*   **High Volatility:** High MDD (Maximum Drawdown) figures indicate very high volatility and significant potential losses.
*   **Low Beta:** Beta values near zero suggest the stock's price is not strongly correlated with the overall market, and may be more influenced by company-specific factors.
*   **Decreasing Cap:** Market cap, indicating the size of the company, has decreased over time, which may have affected its price.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 17.74
*   **Last Market Data:** price: 17.67, previousClose: 18.42, change: -4.05%
*   **5-day SMA:** 17.41
*   **20-day SMA:** 17.57
*   **60-day SMA:** 19.28

**Analysis:**

*   **Downtrend:** The stock price is trading below its 60-day moving average, and the 5-day and 20-day SMAs are close together. Recent market data shows a decrease of -4.05%, indicating short-term negative momentum.

**3) RSI, PPO, Divergence Change, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 47.57 (Neutral)
*   **PPO:** 0.57 (Slightly Bullish)
*   **Hybrid Signal:** Buy 100% of cash (Very Safe, MRI: 0.90)
*   **Recent Divergence Change (20 days):** -3.1 (Short-term decline)
*   **Expected Return (%):** -6482.9 (Extremely Negative)

**Analysis:**

*   **Mixed Signals:** The MRI indicates medium investment risk, but the hybrid signal suggests a "Very Safe" buying opportunity based on a specific allocation strategy. RSI is neutral, while PPO suggests slight bullish momentum.
*   **Negative Outlook:** The expected return is exceptionally negative, suggesting potential significant losses if held long-term. The recent divergence change indicates a short-term downward trend.

**4) Recent News & Significant Events**

*   **Capital Fund Management S.A. Takes $1.49 Million Position in Schrodinger, Inc.**
*   **Unlocking Hidden Value In Schrodinger's Box**
*   **Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now**
*   **US Market Wrap: How SDGR stock performs in rate cut cycles**
*   **A Look at Schr√∂dinger (SDGR) Valuation Following Improved Revenue and Updated Financial Guidance**
*   **Understanding Momentum Shifts in (SDGR)**

**Analysis:**

*   **Mixed Sentiment:** Recent news presents a mixed picture. Some articles suggest buying opportunities ("Buy the Bottom," "Unlocking Hidden Value"), while others focus on momentum shifts and institutional positions. A significant amount of the headlines revolve around potential future benefits, and not actual present profit. This can explain the expected return of -6482.9.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.67 (~Buy)
*   **Opinions:** 9
*   **Target Price (avg/high/low):** 27.22 / 33.00 / 18.00

**Analysis:**

*   **Positive Sentiment:** Analyst consensus leans towards a "Buy" rating, with a mean rating suggesting optimism. The average target price is significantly higher than the current price, suggesting potential upside, but there is a very wide range, indicating that it is difficult to predict.

**5) Recent Earnings Analysis**

| Date       | EPS    | Revenue   |
|------------|--------|-----------|
| 2025-11-05 | -0.45  | 0.05 B$   |
| 2025-08-06 | -0.59  | 0.05 B$   |
| 2025-05-07 | -0.82  | 0.06 B$   |
| 2024-11-12 | -0.52  | 0.04 B$   |
| 2025-11-05 | -0.52  | 0.04 B$   |

**Analysis:**

*   **Consistent Losses:** The company has consistently reported negative EPS (Earnings Per Share), indicating net losses.
*   **Stable Revenue:** Revenue has remained relatively stable.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.05B | 51.61%        |
| 2025-06-30   | $0.05B | 47.77%        |
| 2025-03-31   | $0.06B | 52.26%        |
| 2024-12-31   | $0.09B | 72.61%        |
| 2024-09-30   | $0.04B | 50.24%        |

**Capital and Profitability:**

| Quarter      | Equity | ROE       |
|--------------|--------|-----------|
| 2025-09-30   | $0.32B | -10.21%   |
| 2025-06-30   | $0.34B | -12.59%   |
| 2025-03-31   | $0.37B | -16.01%   |
| 2024-12-31   | $0.42B | -9.54%    |
| 2024-09-30   | $0.45B | -8.49%    |

**Analysis:**

*   **High Profit Margins, Net Losses:** Despite relatively high profit margins on the revenue they generate, the company is still showing net losses overall, as indicated by the negative EPS.
*   **Decreasing Equity:** Equity has been decreasing, which can be a cause for concern, possibly due to continuous losses.
*   **Negative ROE:** Negative ROE (Return on Equity) reflects the company's inability to generate profits from shareholder investments.

**7) Comprehensive Analysis**

Schrodinger Inc. (SDGR) presents a complex picture. The stock has significantly underperformed the S&P 500, demonstrating high volatility and consistent losses. The short-term momentum is negative, and the expected return is extremely poor. However, analyst opinions lean towards a "Buy" rating, and recent news highlights potential hidden value and buying opportunities.

The company's financial performance is characterized by stable revenue, high profit margins, but consistent net losses, decreasing equity, and negative ROE.  While the MRI suggests a medium investment risk, the hybrid signal indicates a safer buying strategy.

**Overall Conclusion:**

Investing in SDGR appears highly speculative. The current data suggests a risky investment with a high probability of losses. While analyst opinions and news articles offer a glimmer of hope for future growth, the company's financial performance and stock's historical underperformance warrant extreme caution. The "Buy" recommendations should be viewed critically, and further due diligence is strongly advised before considering an investment. Investors should weigh the potential upside against the significant risks and negative indicators.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.